| Literature DB >> 30730001 |
Ricardo S Oliveira1, Alan R Barker1, Florian Debras2,3, Sascha H Kranen1, Craig A Williams4.
Abstract
PURPOSE: To investigate the effects of an oral glucose tolerance test (OGTT) on baroreflex sensitivity (BRS) in a sample of healthy adolescents, and how acute exercise bouts of different intensities alter the effects of the OGTT on BRS.Entities:
Keywords: Arterial stiffness; Autonomic system; Oral glucose tolerance test; Youth
Mesh:
Substances:
Year: 2019 PMID: 30730001 PMCID: PMC6423315 DOI: 10.1007/s00421-019-04076-y
Source DB: PubMed Journal: Eur J Appl Physiol ISSN: 1439-6319 Impact factor: 3.078
Fig. 1Overall scheme of visits 2–4. Black arrows: blood sampling. HIIE High-intensity interval exercise, MIIE moderate-intensity interval exercise, CON control, BRS baroreflex sensitivity protocol
Fig. 2Systolic blood pressure and RR interval time series of a representative participant pre- and post-OGTT
Fig. 3Averaged (n = 12) phase, coherence and LFgain at baseline, pre- and post-OGTT for CON, HIIE and MIIE. Shadowed area represents the region of interest (i.e., low frequency range)
Fig. 4Effects of the experimental condition on: a [GLU] (n = 13), b total area under the curve (n = 13) for the different conditions; and c incremental area under the curve (n = 13)
Fig. 5Effects of the experimental condition on the delta changes pre- and post-OGTT for a LFgain (n = 12); b AC (n = 11); and c LFgain/AC (n = 10)
Common carotid, blood pressure and heart rate variability outcomes
| HIIE | MIIE | CON | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Pre-OGTT | Post-OGTT | Δ | Pre-OGTT | Post-OGTT | Δ | Pre-OGTT | Post-OGTT | Δ | |
| DLD (µm) | 5425.5 ± 324.7 | 5465.5 ± 284.0 | 40.0 ± 162.4 | 5417.3 ± 309.2 | 5377.3 ± 387.5 | − 40.0 ± 148.5 | 5400.0 ± 364.4 | 5323.6 ± 370.5 | − 76.4 ± 67.0 |
| SLD (µm) | 6305.5 ± 344.1 | 6335.5 ± 229.9 | 30.0 ± 207.4 | 6322.7 ± 304.3 | 6300.0 ± 341.6 | − 22.7 ± 118.1 | 6268.2 ± 387.6 | 6234.5 ± 355.0 | − 33.6 ± 103.0 |
| ΔD (µm) | 880.0 ± 144.9 | 870.0 ± 131.8 | − 10 ± 106.4 | 905.5 ± 116.2 | 922.7 ± 139.2 | 17.3 ± 122.1 | 868.2 ± 143.2 | 910.9 ± 137.7 | 42.7 ± 62.8 |
| SBP (mmHg) | 108 ± 10 | 110 ± 13 | 1.5 ± 9.8 | 113 ± 9 | 114 ± 15 | 0.3 ± 10.7 | 111 ± 11 | 110 ± 12 | − 0.6 ± 9.4 |
| DBP (mmHg) | 61 ± 6 | 65 ± 9 | 3.9 ± 6.8 | 69 ± 7 | 67 ± 11 | − 1.4 ± 9.6 | 65 ± 6.7 | 66 ± 7 | 0.82 ± 6.4 |
| MAP (mmHg) | 75 ± 6* | 78 ± 10 | 3.2 ± 7.0 | 82 ± 7 | 81 ± 11 | − 0.9 ± 8.7 | 78.9 ± 6.5 | 79 ± 7 | 0.14 ± 5.9 |
| HFln (ms2) | 8.5 ± 0.9 | 8.3 ± 0.8 | − 0.23 ± 0.73 | 8.5 ± 1.0 | 8.4 ± 0.9 | − 0.06 ± 0.79 | 8.4 ± 0.7 | 8.8 ± 0.7 | 0.39 ± 0.43 |
| LFln (ms2) | 7.3 ± 1.2 | 7.0 ± 1.0 | − 0.29 ± 0.61 | 7.2 ± 0.8 | 7.3 ± 0.7 | 0.11 ± 0.60 | 7.5 ± 0.6 | 7.4 ± 0.6 | − 0.15 ± 0.60 |
HIIE High-intensity interval exercise, MIIE moderate-intensity interval exercise, CON control, DLD diastolic lumen diameter, SLD systolic lumen diameter, SBP systolic blood pressure, DBP diastolic blood pressure, MAP mean arterial pressure, HF high frequency, LF low frequency
*P < 0.05 compared to MIIE. For P values and effect sizes refer to text